Brief: LENZ Therapeutics Announces Completion of Merger with Graphite Bio

LENZ Therapeutics

21/03/2024 21:17

March 21 (Reuters) - Graphite Bio Inc  GRPH.O :
    * LENZ THERAPEUTICS:  APPOINTED DAN CHEVALLARD AS CFO ,
EFFECTIVE
MARCH 21, 2024

Source text for Eikon:  ID:nBw1MS4n4a 
Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))